MapLight Therapeutics General Counsel Executes Planned Stock Sale Amid Clinical Trial Milestones
MapLight Therapeutics (NASDAQ:MPLT) has disclosed a significant insider transaction involving its General Counsel, Kristopher Hanson. On May 4, 2026, Mr. Hanson sold a portion of his holdings in the company's common stock, totaling approximately $388,176. The sale consisted of 13,917 shares, which were liquidated at varying price points between $27…